Note
3. Basic and Diluted Net Income (Loss) per Share
The
following table sets forth the computation of the Company’s basic and diluted net income (loss) per share to common stockholders:
Schedule
of Computation of Basic and Diluted Net Loss Per Share
| | |
2024 | | |
2023 | |
| | |
December
31, | |
| | |
2024 | | |
2023 | |
| | |
(In
thousands, except share per share data) | |
| Numerator: | |
| | | |
| | |
| Net
income (loss) | |
$ | (73,297 | ) | |
$ | (135,139 | ) |
| | |
| | | |
| | |
| Denominator: | |
| | | |
| | |
| Basic weighted average
shares outstanding | |
| 847,265 | | |
| 375,922 | |
| Effect
of dilutive securities: | |
| | | |
| | |
| Common
stock warrants | |
| — | | |
| — | |
| Restricted
stock units | |
| — | | |
| — | |
| Common
stock options | |
| — | | |
| — | |
| Diluted weighted average
shares outstanding | |
| 847,265 | | |
| 375,922 | |
| | |
| | | |
| | |
| Net income (loss) per
share | |
| | | |
| | |
| Basic | |
$ | (86.51 | ) | |
$ | (359.49 | ) |
| Diluted | |
$ | (86.51 | ) | |
$ | (359.49 | ) |
Velo3D,
Inc.
Notes
to Consolidated Financial Statements
The
following potentially dilutive shares of common stock equivalents on an “as-converted basis” were excluded from the computation
of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share
| | |
December 31, | |
| | |
2024 | | |
2023 | |
| | |
(per share data) | |
| Common stock warrants | |
| 215,134 | | |
| 97,039 | |
| Restricted stock units | |
| 38,028 | | |
| 38,222 | |
| Common stock options | |
| 18,036 | | |
| 25,053 | |
| Total potentially dilutive common share equivalents | |
| 271,198 | | |
| 160,314 | |
Total
potentially dilutive common share equivalents for the years ended December 31, 2024 and 2023, excludes 17,948 and 40,507,
respectively, shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.
Velo3D,
Inc.
Notes
to Consolidated Financial Statements
|